AAAAAA
Results:
1-19
|
Results: 19
Authors:
Kalemkerian, GP
Ali, MA
Luthra, K
Wozniak, AJ
Valdivieso, M
Kraut, MJ
Citation: Gp. Kalemkerian et al., A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer, CANCER INV, 19(3), 2001, pp. 234-238
Authors:
Kalemkerian, GP
Citation: Gp. Kalemkerian, "But doctor, what have I got to lose ... ?", J CL ONCOL, 19(18), 2001, pp. 3904-3904
Authors:
Gadgeel, SM
Severson, RK
Kau, Y
Graff, J
Weiss, LK
Kalemkerian, GP
Citation: Sm. Gadgeel et al., Impact of race in lung cancer - Analysis of temporal trends from a surveillance, epidemiology, and end results database, CHEST, 120(1), 2001, pp. 55-63
Authors:
Worden, FP
Kalemkerian, GP
Citation: Fp. Worden et Gp. Kalemkerian, Lung cancer, CANC TREAT, 2001, pp. 183-219
Authors:
Worden, FP
Kalemkerian, GP
Citation: Fp. Worden et Gp. Kalemkerian, Therapeutic advances in small cell lung cancer, EXPERT OP I, 9(3), 2000, pp. 565-579
Authors:
Krug, LM
Miller, VA
Kalemkerian, GP
Kraut, MJ
Ng, KK
Heelan, RT
Pizzo, BA
Perez, W
McClean, N
Kris, MG
Citation: Lm. Krug et al., Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer, ANN ONCOL, 11(2), 2000, pp. 227-228
Authors:
Varterasian, ML
Graff, JJ
Severson, RK
Weiss, L
Al-Katib, AM
Kalemkerian, GP
Citation: Ml. Varterasian et al., Non-Hodgkin's lymphoma: An analysis of the Metropolitan Detroit SEER database, CANCER INV, 18(4), 2000, pp. 303-308
Authors:
Ali, MA
Kraut, MJ
Valdivieso, M
Wozniak, AJ
Cummings, G
Kalemkerian, GP
Citation: Ma. Ali et al., A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer, CANCER INV, 18(1), 2000, pp. 1-5
Authors:
Kalemkerian, GP
Ou, XL
Adil, MR
Rosati, R
Khoulani, MM
Madan, SK
Pettit, GR
Citation: Gp. Kalemkerian et al., Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification, CANC CHEMOT, 43(6), 1999, pp. 507-515
Authors:
Kalemkerian, GP
Ou, XL
Citation: Gp. Kalemkerian et Xl. Ou, Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines, CANC CHEMOT, 43(2), 1999, pp. 145-150
Authors:
Gurjal, A
An, T
Valdivieso, M
Kalemkerian, GP
Citation: A. Gurjal et al., Etoposide-induced pulmonary toxicity, LUNG CANC, 26(2), 1999, pp. 109-112
Authors:
Kalemkerian, GP
Belzer, K
Wozniak, AJ
Gaspar, LE
Valdivieso, M
Kraut, MJ
Citation: Gp. Kalemkerian et al., Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer, LUNG CANC, 25(3), 1999, pp. 175-182
Authors:
Weber, E
Ravi, RK
Knudsen, ES
Williams, JR
Dillehay, LE
Nelkin, BD
Kalemkerian, GP
Feramisco, JR
Mabry, M
Citation: E. Weber et al., Retinoic acid-mediated growth inhibition of small cell lung cancer cells is associated with reduced myc and increased p27(Kip1) expression, INT J CANC, 80(6), 1999, pp. 935-943
Authors:
Gadgeel, SM
Ramalingam, S
Cummings, G
Kraut, MJ
Wozniak, AJ
Gaspar, LE
Kalemkerian, GP
Citation: Sm. Gadgeel et al., Lung cancer in patients < 50 years of age - The experience of an academic multidisciplinary program, CHEST, 115(5), 1999, pp. 1232-1236
Authors:
Ohta, Y
Shridhar, V
Kalemkerian, GP
Bright, RK
Watanabe, Y
Pass, HI
Citation: Y. Ohta et al., Thrombospondin-1 expression and clinical implications in malignant pleuralmesothelioma, CANCER, 85(12), 1999, pp. 2570-2576
Authors:
Ohta, Y
Shridhar, V
Bright, RK
Kalemkerian, GP
Du, W
Carbone, M
Watanabe, Y
Pass, HI
Citation: Y. Ohta et al., VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours, BR J CANC, 81(1), 1999, pp. 54-61
Authors:
Rosati, R
Ramnath, N
Adil, MR
Ou, XL
Ali, MA
Heyman, RA
Kalemkerian, GP
Citation: R. Rosati et al., Activity of 9-cis-retinoic acid and receptor-selective retinoids in small cell lung cancer cell lines, ANTICANC R, 18(6A), 1998, pp. 4071-4075
Authors:
Rosati, R
Adil, MR
Ali, MA
Eliason, J
Orosz, A
Sebestyen, F
Kalemkerian, GP
Citation: R. Rosati et al., Induction of apoptosis by a short-chain neuropeptide analog in small cell lung cancer, PEPTIDES, 19(9), 1998, pp. 1519-1523
Authors:
Ali, MA
Kraut, MJ
Valdivieso, M
Herskovic, AM
Du, W
Kalemkerian, GP
Citation: Ma. Ali et al., Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer, LUNG CANC, 22(1), 1998, pp. 39-44
Risultati:
1-19
|